n 79 consecutive patients with unicameral bone cysts we compared the results of aspiration and injection of bone marrow with those of aspiration and injection of steroid. All were treated by the same protocol. The only difference was the substance injected into the cysts. The mean radiological follow-up to detect activity in the cyst was 44 months (12 to 108). Of the 79 patients, 14 received a total of 27 injections of bone marrow and 65 a total of 99 injections of steroid. Repeated injections were required in 57% of patients after bone marrow had been used and in 49% after steroid. No complications were noted in either group. In this series no advantage could be shown for the use of autogenous injection of bone marrow compared with injection of steroid in the management of unicameral bone cysts.
Unicameral bone cysts are benign fluid-containing bone lesions which are predominantly seen in children before skeletal maturity. They are believed to be self-limiting because of their rarity in adults, but repeated pathological fractures and growth arrest may occur before spontaneous resolution.
1,2 Garceau and Gregory 3 reported that healing of bone cysts after pathological fracture occurred in only 14.8% of patients. No cyst showed complete healing after pathological fracture in a series of 97 cases reported by Boseker, Bickel and Dublin 4 and Neer et al 1 reported that repeated fracture occurred in 82% of patients treated by immobilisation and observation for fractures through humeral lesions. Treatment of unicameral bone cysts aims at preventing repeated fracture and prolonged restriction of activity. Open curettage and bone grafting have been used as a primary treatment, but there is a recurrence rate of 18% to 36%. 1, 4, 5 Aspiration and injection of steroid have a similar rate of success [6] [7] [8] and the advantages of a minimal surgical approach, no hospital stay, and very low morbidity. Three or four injections over a period of 12 to 20 months may be required, however, to achieve adequate obliteration of the cyst. 9 In an attempt to achieve higher rates of success with one single intervention, Lokiec and Wientroub 10 advocated injection of bone marrow, together with multiple perforations of the cyst wall and re-establishment of the continuity between the cavity of the cyst and the adjacent normal marrow. They reported a complete rate of healing of 84% after the first treatment which was similar to that described using multiple percutaneous perforations through cortical and medullary bone without injection of bone marrow. 11 It is difficult to separate the effects of mechanical disruption of the integrity of the cyst from those produced by the osteogenic capacity of bone marrow injected into the cyst. Aspiration and injection of steroids was the uniform treatment for unicameral bone cysts in our institution between 1988 and 1996. The treatment was then changed to aspiration and injection of autogenous bone marrow in an attempt to achieve better healing of the cyst.
Our aim in this study was to clarify the osteogenic potential of injection of bone marrow in the treatment of unicameral bone cysts by comparing the results in patients who received injection of steroid without multiple perforations with those in patients who received injection of bone marrow without multiple perforations.
Patients and Methods
There were 79 consecutive patients who fulfilled the following inclusion criteria: 1) a unicameral bone cyst diagnosed by radiological features with clear fluid aspirated from it; 2) treatment by aspiration of the cyst and injection of either steroid or bone marrow at our institution; and 3) follow-up of at least 12 months to confirm a static radiological outcome.
All patients received the same treatment protocol. If there was a pathological fracture, immobilisation was prescribed for four to six weeks before any other intervention. Aspiration and injection with steroid or bone marrow were advised if the cyst persisted after healing of the fracture. Follow-up radiographs were taken six and 12 weeks after each injection. Subsequent aspiration and injection were advised if the cyst persisted. Activity was restricted until satisfactory thickening of the cortex was observed, usually between four and six months after successful injection. Open curettage with allogenic bone grafting was advised if the cyst persisted or recurred after three injections. Radiological follow-up was continued for at least 12 months to detect any activity in the cyst. The radiological result was evaluated using the classification system in Table I which has been adapted from several previous reports. 1, [5] [6] [7] [8] 12, 13 Radiographs, representing each classification, are shown in Figures 1 to 4 . Subsequent injection or open curettage was advised for persistent cysts and recurrent cysts. The patients who showed healing of the cyst with defects were followed annually by serial radiographs. Their activity was not restricted.
The procedures were carried out under general anaesthesia. The thinnest part of the wall of the bone cyst was demonstrated by fluoroscopy. A spinal needle was inserted percutaneously to aspirate the contents of the cyst. A cystogram determined if there were separate cavities. Another needle was inserted if a separate cavity was present. Disruption of the lining membrane of the cyst by the tip of the needle was done incidentally in many cysts, but multiple perforations of the cyst wall were not carried out. Methylprednisolone or autogenous iliac bone marrow was injected into the cyst. The dose of steroid ranged from 80 to 200 mg depending on the body-weight. The bone marrow was aspirated from the anterior iliac crest using an 11-gauge bone-marrow aspiration needle inserted at two or three different sites to harvest 12 to 24 ml of marrow. After the injection, the patient was discharged on the same day.
Injection was considered to be a failure if a subsequent injection or open curettage was undertaken or indicated. It was considered to be successful if the cyst was rated as radiologically healed or healing with a defect and requiring no subsequent treatment. The efficacy of injection of steroid and of bone marrow was compared by determining the rate of failure after each injection.
Additional factors which were analysed included gender, age at injection, previous pathological fracture, the presence of active or latent cysts and the location and size of the cyst. An active cyst was defined as one in which the Table I . Classification of radiological results for unicameral bone cysts
Classification Descriptions
Healed Cyst filled by formation of new bone with ( Fig. 1) or without small static, radiolucent area(s) less than 1 cm in size Healing with defect Static, radiolucent area(s) less than 50% (Fig. 2) of the diameter of bone with enough cortical thickness to prevent fracture Persistent cyst Radiolucent areas greater than 50% of (Fig. 3) diameter of the bone and with a thin cortical rim. No increase in cyst size. Continued restriction of activity or repeated treatment is required Recurrent cyst
Cyst reappeared in a previously obliterated area (Fig. 4) or a residual radiolucent area has increased in size shortest distance from the physis to the margin of the cyst was less than 10 mm. A cyst was declared to be latent if the distance was 10 mm or more. The size of the cyst was defined as the ratio of the length of the cyst to the width of the adjacent physis. This allowed direct comparison of the size without the need for correction factors for differences in age between patients. This method also avoided errors resulting from radiological magnification. We did not calculate the width of the cyst because it was always equal to, or slightly larger than the metaphyseal width. These parameters were evaluated using Student's t-test for continuous variables and the chi-squared test for categorical variables to determine if there was an association between the variables and the results of treatment. 
Results
We evaluated 79 consecutive patients each with a unicameral bone cyst; there were 55 boys (70%) and 24 girls. At presentation, 60 patients (76%) had a pre-existing pathological fracture. The other 19 complained of pain at the site of the lesion; 18 of these lesions were located in the lower limbs. By contrast, in the 47 cysts in the upper limbs, all except one presented with a pathological fracture. Of the 79 patients, 45 had active bone cysts at an age of 7.9 ± 3.5 years and the other 34 patients had latent bone cysts at an age of 10.7 ± 3.6 years. Patients with active cysts were significantly younger (p = 0.001). The cysts were distributed as follows: 46 in the humerus, 23 in the femur, five in the tibia, and five in other sites (calcaneum, 2; fibula, 2; and radius, 1). The most common sites were the proximal humerus (40 cysts, 51%) and the proximal femur (20 cysts, 25%). All the injections were undertaken in the same way by the senior author (RPS). During a mean follow-up period of 44.4 months (12 to 108), 65 patients received a total of 99 injections of steroid and 14 a total of 27 injections of bone marrow. The distribution of gender, age at first injection, the size of the cyst, the presence of active or latent cysts, and the site were not significantly different in the two groups. The failure rate after each injection is shown in Figure 5 . Subsequent injections were required in 49% of patients who had injection of steroid and in 57% who had injection of bone marrow. The rate of failure after injection of steroid was slightly lower than that after injection of bone marrow but the difference was not statistically significant (p > 0.05). Power is equal to 0.76, which means that there was a 76% chance of finding a statistically significant difference if such a difference was present in the population.
The subsequent study of factors related to failure of treatment was performed for humeral or femoral bone cysts treated by aspiration and steroid injection only since the numbers were adequate for statistical analyses. The 38 humeral bone cysts and the 18 femoral bone cysts were similar with regard to the gender of the patient, the size and activity of the cyst, the age at the first steroid injection, and the results of treatment (Table II ). The only difference was the presence or absence of a previous pathological fracture. Only eight of the 18 femoral cysts (44%) had a pathological fracture whereas 37 of the 38 humeral cysts (97%) presented with a pre-existing pathological fracture. After the Bar graph depicting the failure rate after the first and second injections using bone marrow or steroid.
first injection of steroid, 20 humeral cysts and ten femoral cysts healed, with or without small defects, and the remaining 18 humeral cysts and eight femoral cysts persisted or recurred. The 30 cysts which responded successfully to treatment were significantly different from those in which treatment failed in terms of the size of the cyst and the patients' age at treatment (Table III) . Cysts in which the length was less than the width of the adjacent physis (ratio <1.0) had better results than those in which the length was greater than the width of the adjacent physis (failure rate 0% compared with 55%, p < 0.05). Patients over the age of ten years at the first injection had better results than those under the age of ten years (failure rate 28% compared with 57%, p < 0.05). The gender of the patient, active or latent cysts, presence or absence of a previous pathological fracture, and site of the cyst were not significant factors affecting the result of treatment. Similar factor analysis for patients treated by aspiration and injection of bone marrow was not done since the number was not sufficient to produce a meaningful statistical analysis.
Discussion
A standard treatment which achieves the single goal of healing of the cyst has not become established since Virchow first recognised the bone cyst a century ago. All reported methods of treatment from massive subperiosteal diaphysectomy to simple percutaneous injection of steroid result in recurrence in a significant percentage of patients. 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] It is accepted that the more radical the excision of the cysts, the lower is the rate of recurrence. This benign self-limiting bone lesion does not seem to justify radical surgery. Closed methods have been proposed to limit surgical morbidity and to improve the rate of healing after a single intervention. Campanacci et al 6 reported good results after aspiration and injection of methylprednisolone; in 45 of 141 patients (32%) there was recurrence or no response after the first injection of steroid. Scaglietti et al 9 reported that subsequent injections were required in 76% of 163 patients. Hashemi-Nejad and Cole 16 found unsatisfactory radiological results in 59% of 32 patients and stated that the healing response to injection of steroid was unpredictable and usually incomplete. Lokiec et al 21 demonstrated a healing rate of 100% in a preliminary report of ten patients treated by percutaneous autologous marrow grafting in 1996. As a result we changed our standard treatment protocol for managing unicameral bone cysts. This review of our four-year experience of injection of bone marrow demonstrates, however, a failure rate of 57% after the first injection. Yandow et al 20 used the same method in 12 patients, five of whom (42%) required more than one injection of bone marrow. The discrepancy between these results could only be explained by factors other than the osteogenic potential of the injected bone marrow. Multiple perforations through the wall of the cyst into the medullary cavity may be more important in terms of final healing than the choice of injection material. This additional mechanical disruption of the cyst was described in the report of Lokiec et al, 21 * Failure rate in patients over the age of ten years (28%) is significantly less than that in patients under the age of ten years (57%) (p < 0.05). 18 used the same method in 32 patients. A change of nails was required in nine patients (28%), because the nails had become too short for the growing bone. In reviewing the results in the literature and in our patients, the treatments creating communications between the cavity of the cyst and the medullary canal seem to have better results, whether by multiple drilling or by intramedullary nails. A disadvantage of our study is our inability to separate the effects of treatment by cyst puncture from those due to injection of steroid or bone marrow. Compared with other published reports, we made only a single puncture to allow aspiration and injection of the cyst. It is unlikely that such a single puncture was of significance, but this cannot be ruled out. To determine definitively the role of mechanical disruption of the cyst in its resolution would require a prospective, randomised study comparing mechanical disruption of the cyst by multiple perforations with drills or awls with and without injection of steroid.
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